BATS BZX Real-Time Price
As of 2:02pm ET
| +0.22 / +0.38%|
The 27 analysts offering 12-month price forecasts for Novo Nordisk A/S have a median target of 58.69, with a high estimate of 70.18 and a low estimate of 32.89. The median estimate represents a +1.44% increase from the last price of 57.86.
The current consensus among 28 polled investment analysts is to Buy stock in Novo Nordisk A/S. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.